Alfredo Gonzalez is Co-Founder and CEO of Omanta, a San Francisco startup that builds a personalized research lab around each individual patient.
Alfredo earned a PhD in Bioinformatics from UCLA, where he built one of the world's largest centralized multi-omic datasets for rare tumors. He then led genomics research across the Broad Institute, UCLA, and Harvard, with over 10 years in personalized medicine.
Alfredo led the personalized therapeutic campaign behind GitLab co-founder Sid Sijbrandij's complete remission, which directly inspired Omanta. He met his co-founder Ranad Humeidi, PhD, around 2018.
Alfredo co-founded Omanta in 2026 and the company joined Y Combinator's Summer 2026 batch, backed by Y Combinator and Act One Ventures. His prior work spans personalized vaccines, immunotherapies, and radioligands.
Omanta's launch post drew nearly 1 million views on X, and the company was featured in Forbes alongside the YC S26 batch. It serves patients with complex cancers, rare diseases, and undiagnosed conditions who have exhausted standard options.
other founders
